Literature DB >> 32049158

Discordance of Low-Density Lipoprotein Cholestrol and Non-High-Density Lipoprotein Cholestrol and Coronary Artery Disease Severity.

Ozge Kurmus1, Aycan Fahri Erkan1, Berkay Ekici1, Turgay Aslan1, Murat Eren1.   

Abstract

BACKGROUND: A sizeable proportion of patients have discordant low-density lipoprotein cholesterol (LDL-C) and non-high-density lipoprotein cholesterol (non-HDL-C).
OBJECTIVES: We assessed the relationship between discordance of LDL-C and non-HDL-C and coronary artery disease (CAD) severity.
METHODS: We retrospectively evaluated the data of 574 consecutive patients who underwent coronary angiography. Fasting serum lipid profiles were recorded, SYNTAX and Gensini scores were calculated to establish CAD complexity and severity. We determined the medians for LDL-C and non-HDL-C to examine the discordance between LDL-C and non-HDL-C. Discordance was defined as LDL-C greater than or equal to the median and non-HDL-C less than median; or LDL-C less than median and non-HDL-C greater than or equal to median. A p value < 0.05 was accepted as statistically significant.
RESULTS: LDL-C levels were strongly and positively correlated with non-HDL-C levels (r = 0.865, p < 0.001) but 15% of patients had discordance between LDL-C and non-HDL-C. The percentage of patients with a Gensini score of zero or SYNTAX score of zero did not differ between discordant or concordant groups (p = 0.837, p = 0.821, respectively). Mean Gensini and SYNTAX scores, percentage of patients with Gensini score ≥20 and SYNTAX score >22 were not different from group to group (p = 0.635, p = 0.733, p = 0.799, p = 0.891, respectively). Also, there was no statistically significant correlation between LDL-C and Gensini or SYNTAX scores in any of the discordant or concordant groups. Additionally, no correlation was found between non-HDL-C and Gensini or SYNTAX score.
CONCLUSIONS: While there was discordance between LDL-C and non-HDL-C (15% of patients), there is no difference regarding CAD severity and complexity between discordant and concordant groups.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32049158      PMCID: PMC7792727          DOI: 10.36660/abc.20190091

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN: 0066-782X            Impact factor:   2.000


  32 in total

1.  AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute.

Authors:  Sidney C Smith; Jerilyn Allen; Steven N Blair; Robert O Bonow; Lawrence M Brass; Gregg C Fonarow; Scott M Grundy; Loren Hiratzka; Daniel Jones; Harlan M Krumholz; Lori Mosca; Richard C Pasternak; Thomas Pearson; Marc A Pfeffer; Kathryn A Taubert
Journal:  Circulation       Date:  2006-05-16       Impact factor: 29.690

2.  2016 ESC/EAS Guidelines for the Management of Dyslipidaemias.

Authors:  Alberico L Catapano; Ian Graham; Guy De Backer; Olov Wiklund; M John Chapman; Heinz Drexel; Arno W Hoes; Catriona S Jennings; Ulf Landmesser; Terje R Pedersen; Željko Reiner; Gabriele Riccardi; Marja-Riita Taskinen; Lale Tokgozoglu; W M Monique Verschuren; Charalambos Vlachopoulos; David A Wood; Jose Luis Zamorano; Marie-Therese Cooney
Journal:  Eur Heart J       Date:  2016-08-27       Impact factor: 29.983

Review 3.  Discordance analysis and the Gordian Knot of LDL and non-HDL cholesterol versus apoB.

Authors:  Allan D Sniderman; Benoit Lamarche; John H Contois; Jacqueline de Graaf
Journal:  Curr Opin Lipidol       Date:  2014-12       Impact factor: 4.776

4.  Variability in cholesterol content and physical properties of lipoproteins containing apolipoprotein B-100.

Authors:  N Abate; G L Vega; S M Grundy
Journal:  Atherosclerosis       Date:  1993-12       Impact factor: 5.162

Review 5.  Non-high-density lipoprotein cholesterol: current status as cardiovascular marker.

Authors:  Rutger Verbeek; G Kees Hovingh; S Matthijs Boekholdt
Journal:  Curr Opin Lipidol       Date:  2015-12       Impact factor: 4.776

6.  Relation of Plasma Lipoprotein(a) to Subclinical Coronary Plaque Volumes, Three-Vessel and Left Main Coronary Disease, and Severe Coronary Stenoses in Apparently Healthy African-Americans With a Family History of Early-Onset Coronary Artery Disease.

Authors:  Brian G Kral; Rita R Kalyani; Lisa R Yanek; Dhananjay Vaidya; Elliot K Fishman; Diane M Becker; Lewis C Becker
Journal:  Am J Cardiol       Date:  2016-07-05       Impact factor: 2.778

7.  Discordance analysis of apolipoprotein B and non-high density lipoprotein cholesterol as markers of cardiovascular risk in the INTERHEART study.

Authors:  Allan D Sniderman; Shofique Islam; Salim Yusuf; Matthew J McQueen
Journal:  Atherosclerosis       Date:  2012-09-23       Impact factor: 5.162

8.  Concordance/discordance between plasma apolipoprotein B levels and the cholesterol indexes of atherosclerotic risk.

Authors:  Allan D Sniderman; Annie C St-Pierre; Bernard Cantin; Gilles R Dagenais; Jean-Pierre Després; Benoît Lamarche
Journal:  Am J Cardiol       Date:  2003-05-15       Impact factor: 2.778

9.  Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment.

Authors:  John J P Kastelein; Wim A van der Steeg; Ingar Holme; Michael Gaffney; Nilo B Cater; Philip Barter; Prakash Deedwania; Anders G Olsson; S Matthijs Boekholdt; David A Demicco; Michael Szarek; John C LaRosa; Terje R Pedersen; Scott M Grundy
Journal:  Circulation       Date:  2008-06-02       Impact factor: 29.690

10.  Discordance of low-density lipoprotein (LDL) cholesterol with alternative LDL-related measures and future coronary events.

Authors:  Samia Mora; Julie E Buring; Paul M Ridker
Journal:  Circulation       Date:  2013-12-17       Impact factor: 29.690

View more
  2 in total

1.  Discordant serum lipid parameters.

Authors:  Ozge Kurmus; Turgay Aslan; Murat Eren; Kursat Akbuga; Liliana Fonseca; Silvia Paredes; Isabel Palma
Journal:  Lipids Health Dis       Date:  2021-02-11       Impact factor: 3.876

2.  Discordance of Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol with Severity of Coronary Artery Disease.

Authors:  Iran Castro; Hugo Fontana Filho
Journal:  Arq Bras Cardiol       Date:  2020 May-Jun       Impact factor: 2.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.